Blog articles

The WDTA supports expanding workplace drug and alcohol testing to executives, promoting accountability, safety, and responsibility across all professional sectors.

Key insights from a webinar on medicinal cannabis in the workplace: the importance of clear drug policies, medication privacy, and addressing safety risks, with a focus on testing methods and employer responsibilities

Breath alcohol testing (BrAC, g/210L) is now the industry standard — read about breath vs blood measurements and the implications for AOD policies.

As cannabis use grows in Australia and New Zealand, doctors must discuss its health risks, interactions, and workplace implications with patients using or considering medicinal THC.

As medicinal and recreational cannabis use rises in Australia and New Zealand, healthcare professionals need to engage in informed discussions with patients about its health implications.

The rise of working from home during COVID-19 has increased risks of substance use affecting work performance and safety. Testing remains essential to maintain a drug- and alcohol-free workplace, whether on-site or remote.

To meet industry requirements for Covid19 Rapid Antigen Testing and PCR Collection

International use of prescribed medicinal cannabis is rising. Workplaces must balance legal compliance with safety, considering THC’s effects and testing, while managing disclosure, risk assessment, and appropriate policy frameworks.

Positive drug test results for cocaine and marijuana are rising among federally mandated, safety-sensitive workers, highlighting growing workplace safety concerns.

The 2022 Quest Diagnostics Drug Testing Index shows rising drug use in the US workforce, highlighting why comprehensive workplace drug testing is essential for safety and productivity.

COVID-19 has changed workplace drug testing, with risks of drug and alcohol misuse rising while OH&S and pandemic measures take staff focus away from traditional safety checks.

Wastewater analysis reveals the types and amounts of drugs Australians consume, highlighting regional methamphetamine use and its implications for workplace safety.

COVID-19 has increased stress and altered drug use patterns, highlighting the growing importance of workplace drug testing as businesses adapt to the “new normal.”

Alcohol consumption has risen during the pandemic, increasing risks in safety-sensitive workplaces across Australia.

COVID-19 has increased the need for workplace drug and alcohol testing, as remote work and isolation can raise risks and reduce safety culture.

Australia’s workplace drug testing programs, used by millions of employees, offer a robust, accurate, and legally defensible model for random testing schemes.

Since 1 February 2018, codeine in Australia is prescription-only, meaning workplace drug tests now only flag prescription opiates, affecting declared medication policies.